Consultation on charges for controlled drug licences and precursor chemical licences, registrations, and authorisations
This consultation considered charging options for controlled drug licences, precursor chemical licences, registrations, and authorisations.
Detail
On 29 March the Home Office launched a consultation on the proposal to introduce charges for controlled drug licences, and precursor chemical licences, registrations, and authorisations.
This consultation paper considered different options for charging. It is accompanied by a consultation stage impact assessment that outlines the costs and benefits of the different options.
Documents
Summary of consultation responses - charges for controlled drug licences application/pdfSummary of responses for the consultation on charges for controlled drug licences and precursor chemical licences, registrations, and authorisations.application/pdfThis is an updated impact assessment for the introduction of charges for controlled drug and precursor chemical licences.application/pdfUpdated impact assessment - charges for controlled drug licences application/pdfConsultation on charges for controlled drug licences and precursor chemical licences, registrations, and authorisations application/pdfThis consultation is considering different options for charging for controlled drug licences, and precursor chemical licences, registrations, and authorisations.application/pdfImpact assessment re-introduction of charges for drugs licences application/pdfThis impact assessment outlines the cost and benefits of the different options.application/pdfSummary Of Responses: Home Office Consultation On The Introduction Of Charges For Controlled Drug And Precursor Chemical Licencesapplication/pdf